Peter Ellis
Impact in
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
Papers in
- Oncology 77
- Lung Cancer Research Studies 20
-
- Palliative Care and End-of-Life Issues 21
- Co-authors
- Phyllis Noemi Butow (6 shared papers)Martin H.N. Tattersall (5 shared papers)ANDREW S. BELL (3 shared papers)David Brown (2 shared papers)Nicholas Kenneth Terrett (1 shared paper)Cordelia Langford (9 shared papers)Sharron H. Francis (1 shared paper)Robert M. Wallis (1 shared paper)
- Journals
- Annals of Oncology (16 papers)Nature (10 papers)Journal of Clinical Oncology (9 papers)Journal of Thoracic Oncology (9 papers)European Journal of Cancer (9 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Peter Ellis
512 papers receiving 29.4k citations
Peter Ellis's Hit Papers
Peers
Comparison fields: 5 of 228
- Cancer Research 4.6k
- Hematology 2.7k
- Oncology 4.3k
- Molecular Biology 11.3k
- Genetics 1.5k
Countries citing papers authored by Peter Ellis
This map shows the geographic impact of Peter Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ellis more than expected).
Fields of papers citing papers by Peter Ellis
This network shows the impact of papers produced by Peter Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ellis. The network helps show where Peter Ellis may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Ellis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 591 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project Hit paper breakdown → | 2007 | 4022 |
| 2 | Clinical and biological implications of driver mutations in myelodysplastic syndromes Hit paper breakdown → | 2013 | 1540 |
| 3 | High burden and pervasive positive selection of somatic mutations in normal human skin Hit paper breakdown → | 2015 | 1334 |
| 4 | SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts Hit paper breakdown → | 2011 | 1036 |
| 5 | The UK10K project identifies rare variants in health and disease Hit paper breakdown → | 2015 | 760 |
| 6 | SARS-CoV-2 evolution during treatment of chronic infection Hit paper breakdown → | 2021 | 698 |
| 7 | G&T-seq: parallel sequencing of single-cell genomes and transcriptomes Hit paper breakdown → | 2015 | 579 |
| 8 | Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction Hit paper breakdown → | 1996 | 549 |
| 9 | 2006 | 548 | |
| 10 | Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Hit paper breakdown → | 2021 | 524 |
| 11 | The landscape of somatic mutation in normal colorectal epithelial cells Hit paper breakdown → | 2019 | 517 |
| 12 | 2008 | 504 | |
| 13 | 2009 | 483 | |
| 14 | 1999 | 457 | |
| 15 | Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial Hit paper breakdown → | 2013 | 452 |
| 16 | 2006 | 447 | |
| 17 | 2003 | 417 | |
| 18 | 2005 | 412 | |
| 19 | 2012 | 390 | |
| 20 | 2005 | 365 |
About Peter Ellis
Peter Ellis is a scholar working on Oncology, Public Health, Environmental and Occupational Health, General Health Professions, Pulmonary and Respiratory Medicine and Cancer Research, having authored 591 papers that have together received 30.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (23 papers), Palliative Care and End-of-Life Issues (21 papers), Lung Cancer Research Studies (20 papers), Breast Cancer Treatment Studies (16 papers), Legal Rights and Human Rights (16 papers), Cancer Genomics and Diagnostics (16 papers), Lung Cancer Diagnosis and Treatment (16 papers) and Ethics in medical practice (15 papers). The work is most often cited by research in Cancer Research (4.6k citations), Hematology (2.7k citations), Oncology (4.3k citations), Molecular Biology (11.3k citations) and Genetics (1.5k citations). Peter Ellis has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Phyllis Noemi Butow, Martin H.N. Tattersall, ANDREW S. BELL, David Brown, Nicholas Kenneth Terrett, Cordelia Langford, Sharron H. Francis, Robert M. Wallis, Jackie D. Corbin and Iñigo Martincorena. Their work appears in journals such as Annals of Oncology, Nature, Journal of Clinical Oncology, Journal of Thoracic Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.